156. Rett syndrome Clinical trials / Disease details


Clinical trials : 44 Drugs : 61 - (DrugBank : 23) / Drug target genes : 57 - Drug target pathways : 83

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02715115
(ClinicalTrials.gov)
March 201621/2/2016A Safety Study of NNZ-2566 in Pediatric Rett SyndromeA Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett SyndromeRett SyndromeDrug: NNZ-2566;Drug: PlaceboNeuren Pharmaceuticals Limitedrettsyndrome.orgCompleted5 Years15 YearsFemale82Phase 2United States
2NCT01703533
(ClinicalTrials.gov)
March 20134/10/2012A Safety Study of NNZ-2566 in Patients With Rett SyndromeA Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Escalation Study of NNZ-2566 in Rett SyndromeRett SyndromeDrug: NNZ-2566;Drug: PlaceboNeuren Pharmaceuticals LimitedBaylor College of Medicine;International Rett Syndrome FoundationCompleted16 Years45 YearsFemale67Phase 2United States